Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Amniotic Fluid for COVID-19
NCT04497389Phase 2Completed
- Sponsor
- University of Utah
- Start
- Oct 2020
- Primary completion
- Aug 2022
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of processed amniotic fluid in coronavirus disease 2019 (COVID-19), sponsored by University of Utah. Started Oct 2020; status: completed.
02
Drugs
processed amniotic fluid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04497389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04497389.